MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Clinical trial NCT00147550 · TERMINATED

Trial details

NCT number: NCT00147550
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Colonic Neoplasms Breast Neoplasms

Start date: 2004-02-01
Primary completion: 2007-05-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.